Breast Cancer

>

Latest News

Camizestrant showed better progression-free survival than fulvestrant across various subgroups of patients with advanced breast cancer.
Camizestrant Significantly Improves PFS in HER2– Breast Cancer

November 12th 2024

Camizestrant showed better progression-free survival than fulvestrant across various subgroups of patients with advanced breast cancer.

Treatment with (Z)-endoxifen yielded no changes in hematological safety tests among patients enrolled on the phase 2 KARISMA-Endoxifen study.
Novel SERM Reduces Mammographic Breast Density in Premenopausal Population

November 5th 2024

Inavolisib-based therapy reaches the primary end point of the phase 3 INAVO120 study among patients with PIK3CA-mutated breast cancer.
Inavolisib-Based Therapy Boosts Progression-Free Survival in Breast Cancer

November 1st 2024

Findings speak to the need of cultural, racial, and ethnic inclusion when designing breast cancer trials and developing patient-reported outcome measures.
Study Shows Post-Mastectomy Disparities in Breast Cancer Minority Groups

October 31st 2024

Four of 13 patients with metastatic breast cancer recruited in 2022 for the phase 2 clinical study evaluating Bria-IMT remain in survival follow-up.
Bria-IMT Regimen Exceeds Survival Data of SOC in Metastatic Breast Cancer

October 23rd 2024

Latest CME Events & Activities

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

<1
...
132133134135136